GlassScriptPhysician profile
Sapna V Desai
NPI 1538335500
$29,583.38
in general payments reported to CMS, 2019-2025
28 companies · $1,377 in 2025
The $1,377 reported for 2025 was more than what a typical Advanced Heart Failure and Transplant Cardiology provider received nationally (typical 2025 total: $1,046).
See the full distribution for Advanced Heart Failure and Transplant Cardiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $15K · 2020: $269 · 2021: $6,607 · 2022: $2,398 · 2023: $2,394 · 2024: $1,134 · 2025: $1,377.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,703 · Travel and Lodging: $1,014 · Education: $188.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,702.94 |
| Travel and Lodging | $1,013.84 |
| Education | $187.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $23,684.00 | 2019-2025 | Thoratec Heartmate 3 Lvas Implant Kit, Cardiomems |
| Abiomed | $3,421.08 | 2019-2025 | Impella |
| Actelion Pharmaceuticals US, INC. | $389.41 | 2022-2025 | Uptravi, Opsumit |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $265.24 | 2023-2025 | Lifevest |
| United Therapeutics Corporation | $243.22 | 2021-2025 | Orenitram |
| E.R. Squibb & Sons, L.L.C. | $234.91 | 2022-2025 | Camzyos |
| Shockwave Medical, INC | $230.95 | 2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Pfizer INC. | $155.41 | 2019-2025 | |
| Novo Nordisk INC | $154.83 | 2024-2025 | Wegovy |
| Novartis Pharmaceuticals Corporation | $147.19 | 2021-2025 | |
| Alnylam Pharmaceuticals INC. | $117.13 | 2022-2025 | Onpattro |
| Cvrx, INC. | $97.88 | 2019-2025 | Barostim Neo System |
| Merck Sharp & Dohme LLC | $63.14 | 2024-2025 | Verquvo, Winrevair |
| Scpharmaceuticals INC. | $55.32 | 2024-2025 | |
| Janssen Pharmaceuticals, INC | $48.72 | 2020-2024 | Xarelto |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $45.24 | 2022-2023 | Farxiga |
| Mannkind Corporation | $25.04 | 2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $23.82 | 2022 | |
| Cardiac Dimensions, INC. | $23.79 | 2025 | |
| Kestra Medical Technology Services, INC. | $22.29 | 2025 | Assure Wcd |
| Livanova USA, INC. | $22.05 | 2022 | |
| Amgen INC. | $21.96 | 2021 | |
| Bridgebio Pharma, INC. | $20.31 | 2025 | Attruby |
| Mallinckrodt Enterprises LLC | $19.98 | 2019 | |
| Medtronic Vascular, INC. | $18.95 | 2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $17.02 | 2024 | Jardiance |
| Sanofi-Aventis U.S. LLC | $14.50 | 2021 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sapna Desai listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.